Discontinued — last reported Q4 '25
AT&T Acquisitions increased by 705.4% to $2.67B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 13270.0%, from $20.00M to $2.67B. Over 4 years (FY 2021 to FY 2025), Acquisitions shows a downward trend with a -65.1% CAGR.
High spending indicates an aggressive growth strategy, while low spending may indicate a focus on organic growth or debt reduction.
This represents the net cash outflow for the purchase of other businesses or strategic assets, adjusted for any cash acq...
Highly variable; pharmaceutical companies frequently use M&A to offset patent cliffs and expand therapeutic portfolios.
acquisitions| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $285.00M | $364.00M | $1.92B | $9.24B | $326.00M | $389.00M | $241.00M | $291.00M | $224.00M | $408.00M | $2.02B | $211.00M | $59.00M | $52.00M | $58.00M | $20.00M | $28.00M | -$1.00M | $332.00M | $2.67B |
| QoQ Change | — | +27.7% | +427.5% | +381.5% | -96.5% | +19.3% | -38.0% | +20.7% | -23.0% | +82.1% | +394.9% | -89.5% | -72.0% | -11.9% | +11.5% | -65.5% | +40.0% | -103.6% | >999% | +705.4% |
| YoY Change | — | — | — | — | +14.4% | +6.9% | -87.4% | -96.9% | -31.3% | +4.9% | +737.8% | -27.5% | -73.7% | -87.3% | -97.1% | -90.5% | -52.5% | -101.9% | +472.4% | >999% |